Express Scripts to Present at Upcoming Conferences

              Express Scripts to Present at Upcoming Conferences

PR Newswire

ST. LOUIS, May 8, 2013

ST. LOUIS, May 8, 2013 /PRNewswire/ --Express Scripts (Nasdaq: ESRX)
announced that it will present at the following conferences:

  oBank of America Merrill Lynch 2013 Healthcare Conference on Thursday, May
    16, 2013 at 10:00 a.m. Pacific (1:00 p.m. Eastern).
  oUBS Global Healthcare Conference on Tuesday, May 21, 2013 at 1:30 p.m.

These presentations will also be broadcast via the Internet and can be
accessed on the investor relations section of Express Scripts web site at RealPlayer or Windows Media Player is needed
to listen to the Webcasts and free downloads of these players are available at
the Webcast site. The Webcasts will be archived and available for replay for
14 days.

Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each
year for tens of millions of patients. On behalf of our clients – employers,
health plans, unions and government health programs – we make the use of
prescription drugs safer and more affordable. Express Scripts uniquely
combines three capabilities – behavioral sciences, clinical specialization and
actionable data – to create Health Decision Science^SM, our innovative
approach to help individuals make the best drug choices, pharmacy choices and
health choices. Better decisions mean healthier outcomes.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy
benefit management services, including network-pharmacy claims processing,
home delivery, specialty benefit management, benefit-design consultation,
drug-utilization review, formulary management, and medical and drug data
analysis services. The company also distributes a full range of
biopharmaceutical products and provides extensive cost-management and
patient-care services.

For more information, visit or follow @ExpressScripts
on Twitter.

SOURCE Express Scripts

Contact: Jeffrey Hall, Chief Financial Officer, David Myers, Vice President
Investor Relations, +1-314- 810-3115,
Press spacebar to pause and continue. Press esc to stop.